A Splicing Variant of the Androgen Receptor Detected in a Metastatic Prostate Cancer Exhibits Exclusively Cytoplasmic Actions.
From: Faculté de Médecine/Signalisation et Cancer de la Prostate/Equipe d’Accueil 3430, Université Strasbourg, Strasbourg, France.
Endocrinology
- Publish Date: Sep 2007
- ISSN: 0013-7227
- Volume: 148
- Issue: 9
- Pages: 4334-43
- Medium: Print
- Language: English
- Citation (JAMA): Jagla Monika, Fève Marie, Kessler Pascal, et al. A Splicing Variant of the Androgen Receptor Detected in a Metastatic Prostate Cancer Exhibits Exclusively Cytoplasmic Actions.. Endocrinology Sep 2007;148:4334-43
Abstract
The androgen receptor (AR) is a ligand-activated transcription factor that displays genomic actions characterized by binding to androgen-response elements in the promoter of target genes as well as nongenomic actions that do not require nuclear translocation and DNA binding. In this study, we report exclusive cytoplasmic actions of a splicing variant of the AR detected in a metastatic prostate cancer. This AR variant, named AR23, results from an aberrant splicing of intron 2, wherein the last 69 nucleotides of the intronic sequence are retained, leading to the insertion of 23 amino acids between the two zinc fingers in the DNA-binding domain. We show that the nuclear entry of AR23 upon dihydrotestosterone (DHT) stimulation is impaired. Alternatively, DHT-activated AR23 forms cytoplasmic and perinuclear aggregates that partially colocalize with the endoplasmic reticulum and are devoid of genomic actions. However, in LNCaP cells, this cytoplasmic DHT-activated AR23 remains partially active as evidenced by the activation of transcription from androgen-responsive promoters, the stimulation of NF-kappaB transcriptional activity and by the decrease of AP-1 transcriptional activity. Our data reveal novel cytoplasmic actions for this splicing AR variant, suggesting a contribution in prostate cancer progression.
Mesh Headings (Keywords): Alternative Splicing, Animals, COS Cells, Cell Line, Tumor, Cercopithecus aethiops, DNA, Complementary, Gene Amplification, Haplorhini, Humans, Male, Neoplasm Metastasis, Prostatic Neoplasms, Receptors, Androgen, Restriction Mapping, Transfection, Variation (Genetics)
Check for Full Text / PubMed Unique Identifier (PMID): 17540719
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.